TTM
17.2%
YoY change
+4.45pp
Trough year (2021)
0.3%
Peak year (2011)
29.5%
Latest annual
17.5%
Net Profit Margin history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: 17.5%
Net Profit Margin change chart for AstraZeneca (AZN) from 1990 to 2025
Latest: +4.45pp
Net Profit Margin history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | 17.5% | +4.45pp | ||
| 2024 | 13.0% | +0.01pp | ||
| 2023 | 13.0% | +5.59pp | ||
| 2022 | 7.4% | +7.11pp | ||
| 2021 | 0.3% | -11.71pp | ||
| 2020 | 12.0% | +6.53pp | ||
| 2019 | 5.5% | -4.28pp | ||
| 2018 | 9.8% | -3.60pp | ||
| 2017 | 13.4% | -1.85pp | ||
| 2016 | 15.2% | +3.78pp | ||
| 2015 | 11.4% | +6.79pp | ||
| 2014 | 4.6% | -5.26pp | ||
| 2013 | 9.9% | -12.40pp | ||
| 2012 | 22.3% | -7.22pp | ||
| 2011 | 29.5% | +5.32pp | ||
| 2010 | 24.2% | +1.28pp | ||
| 2009 | 22.9% | +3.62pp | ||
| 2008 | 19.3% | +0.38pp | ||
| 2007 | 18.9% | -3.90pp | ||
| 2006 | 22.8% | +3.18pp | ||
| 2005 | 19.6% | +2.55pp | ||
| 2004 | 17.1% | +0.99pp | ||
| 2003 | 16.1% | +0.20pp | ||
| 2002 | 15.9% | -9.32pp | ||
| 2001 | 25.2% | +11.20pp | ||
| 2000 | 14.0% | +6.48pp | ||
| 1999 | 7.5% | -2.92pp | ||
| 1998 | 10.5% | -3.58pp | ||
| 1997 | 14.1% | +2.07pp | ||
| 1996 | 12.0% | +5.13pp | ||
| 1995 | 6.9% | -3.03pp | ||
| 1994 | 9.9% | +0.18pp | ||
| 1993 | 9.7% | +7.70pp | ||
| 1992 | 2.0% | -6.77pp | ||
| 1991 | 8.8% | +2.95pp | ||
| 1990 | 5.8% | — |
- 202517.5%+4.45pp
- 202413.0%+0.01pp
- 202313.0%+5.59pp
- 20227.4%+7.11pp
- 20210.3%-11.71pp
- 202012.0%+6.53pp
- 20195.5%-4.28pp
- 20189.8%-3.60pp
- 201713.4%-1.85pp
- 201615.2%+3.78pp
- 201511.4%+6.79pp
- 20144.6%-5.26pp
- 20139.9%-12.40pp
- 201222.3%-7.22pp
- 201129.5%+5.32pp
- 201024.2%+1.28pp
- 200922.9%+3.62pp
- 200819.3%+0.38pp
- 200718.9%-3.90pp
- 200622.8%+3.18pp
- 200519.6%+2.55pp
- 200417.1%+0.99pp
- 200316.1%+0.20pp
- 200215.9%-9.32pp
- 200125.2%+11.20pp
- 200014.0%+6.48pp
- 19997.5%-2.92pp
- 199810.5%-3.58pp
- 199714.1%+2.07pp
- 199612.0%+5.13pp
- 19956.9%-3.03pp
- 19949.9%+0.18pp
- 19939.7%+7.70pp
- 19922.0%-6.77pp
- 19918.8%+2.95pp
- 19905.8%—
Net Profit Margin values are taken from AstraZeneca's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Profit Margin at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported net margin is 17.2%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AstraZeneca (AZN) most recent annual net margin stands at 17.46% (2025) – expanded 4.4 percentage points year-over-year.
29.52% stands as the all-time-high annual net margin, posted in 2011, against a low of 0.30% during 2021.
AstraZeneca Net Profit Margin by Year
AstraZeneca Net Profit Margin 2025: 17.5%
AstraZeneca net margin in 2025 was 17.46%, expanded 4.4 percentage points from 2024.
AstraZeneca Net Profit Margin 2024: 13.0%
2024's net margin for AstraZeneca came in at 13.01%, expanded 0.0 percentage points from 2023.
AstraZeneca Net Profit Margin 2023: 13.0%
AstraZeneca posted net margin of 13.00% in 2023, expanded 5.6 percentage points from 2022.
AstraZeneca Net Profit Margin 2022: 7.4%
In 2022, AstraZeneca reported net margin of 7.41%, expanded 7.1 percentage points from 2021.
AstraZeneca Net Profit Margin 2021: 0.3%
AstraZeneca net margin in 2021 was 0.30%.
See more financial history for AstraZeneca (AZN).
Sector peers by Net Profit Margin
Healthcare peers of AstraZeneca (AZN), ranked by their latest net margin
| 37.2% | |
| 35.0% | |
| 21.4% | |
| 20.9% | |
| 15.2% | |
| 13.6% | |
| 5.8% | |
| 2.7% |
- 37.2%
- 35.0%
- 20.9%
- 13.6%
- 5.8%
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation